Intermede Investment Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $79.8M | Sell |
270,331
-14,628
| -5% | -$4.34M | 3.7% | 10 |
|
|
2025
Q4 | $77.8M | Buy |
+284,959
| New | +$77.4M | 3.2% | 12 |
|
|
2025
Q1 | – | Sell |
-556,034
| Closed | -$129M | – | 34 |
|
|
2024
Q4 | $129M | Sell |
556,034
-153,697
| -22% | -$35.3M | 3.45% | 11 |
|
|
2024
Q3 | $157M | Sell |
709,731
-13,639
| -2% | -$2.82M | 3.27% | 11 |
|
|
2024
Q2 | $142M | Sell |
723,370
-48,006
| -6% | -$9.92M | 3.01% | 15 |
|
|
2024
Q1 | $166M | Sell |
771,376
-246,777
| -24% | -$51.8M | 3.39% | 12 |
|
|
2023
Q4 | $214M | Sell |
1,018,153
-49,926
| -5% | -$10.7M | 4.87% | 6 |
|
|
2023
Q3 | $214M | Sell |
1,068,079
-42,367
| -4% | -$8.42M | 5.48% | 5 |
|
|
2023
Q2 | $206M | Sell |
1,110,446
-1,156
| -0.1% | -$214K | 4.8% | 7 |
|
|
2023
Q1 | $213M | Sell |
1,111,602
-110,855
| -9% | -$20M | 5.22% | 6 |
|
|
2022
Q4 | $206M | Buy |
1,222,457
+104,111
| +9% | +$18.1M | 5.74% | 4 |
|
|
2022
Q3 | $198M | Buy |
1,118,346
+82,142
| +8% | +$16.2M | 5.55% | 4 |
|
|
2022
Q2 | $212M | Buy |
1,036,204
+29,987
| +3% | +$6.36M | 5.88% | 4 |
|
|
2022
Q1 | $239M | Buy |
1,006,217
+66,208
| +7% | +$15.5M | 5.6% | 4 |
|
|
2021
Q4 | $215M | Sell |
940,009
-32,874
| -3% | -$7.23M | 4.42% | 8 |
|
|
2021
Q3 | $188M | Sell |
972,883
-9,774
| -1% | -$1.98M | 4.33% | 6 |
|
|
2021
Q2 | $209M | Buy |
982,657
+46,903
| +5% | +$9.9M | 4.75% | 6 |
|
|
2021
Q1 | $191M | Buy |
935,754
+155,129
| +20% | +$30.6M | 4.88% | 5 |
|
|
2020
Q4 | $142M | Buy |
780,625
+243,181
| +45% | +$41.4M | 4.11% | 13 |
|
|
2020
Q3 | $89.9M | Buy |
537,444
+20,580
| +4% | +$3.47M | 3.76% | 16 |
|
|
2020
Q2 | $84M | Buy |
516,864
+12,418
| +2% | +$2.23M | 4.11% | 15 |
|
|
2020
Q1 | $87.2M | Buy |
504,446
+20,235
| +4% | +$4.03M | 5.14% | 7 |
|
|
2019
Q4 | $97.2M | Buy |
484,211
+7,797
| +2% | +$1.6M | 4.92% | 8 |
|
|
2019
Q3 | $101M | Sell |
476,414
-5,584
| -1% | -$1.17M | 5.59% | 2 |
|
|
2019
Q2 | $93.6M | Sell |
481,998
-7,306
| -1% | -$1.35M | 5.54% | 2 |
|
|
2019
Q1 | $80.5M | Buy |
489,304
+58,754
| +14% | +$10.4M | 5.01% | 6 |
|
|
2018
Q4 | $81M | Buy |
430,550
+21,506
| +5% | +$3.97M | 6.47% | 1 |
|
|
2018
Q3 | $69.6M | Buy |
409,044
+16,286
| +4% | +$2.74M | 5.22% | 5 |
|
|
2018
Q2 | $64.4M | Sell |
392,758
-13,136
| -3% | -$2.15M | 5.09% | 4 |
|
|
2018
Q1 | $65.6M | Sell |
405,894
-23,297
| -5% | -$3.71M | 5.64% | 3 |
|
|
2017
Q4 | $62.7M | Buy |
429,191
+19,814
| +5% | +$2.82M | 5.33% | 5 |
|
|
2017
Q3 | $55.5M | Buy |
409,377
+1,009
| +0.2% | +$127K | 5.08% | 7 |
|
|
2017
Q2 | $51.1M | Buy |
408,368
+74,393
| +22% | +$8.9M | 4.95% | 8 |
|
|
2017
Q1 | $39.7M | Sell |
333,975
-24,043
| -7% | -$2.89M | 4.15% | 9 |
|
|
2016
Q4 | $41.3M | Sell |
358,018
-9,460
| -3% | -$1.05M | 4.84% | 5 |
|
|
2016
Q3 | $38.4M | Buy |
367,478
+4,529
| +1% | +$473K | 4.25% | 9 |
|
|
2016
Q2 | $35.4M | Buy |
362,949
+7,286
| +2% | +$689K | 4.1% | 11 |
|
|
2016
Q1 | $34.2M | Buy |
355,663
+103,892
| +41% | +$9.45M | 4.12% | 11 |
|
|
2015
Q4 | $22.8M | Buy |
+251,771
| New | +$23.7M | 3.86% | 13 |
|
Other funds holding CME
VCM
VPM
Intermede Investment Partners's CME Position: Q1 2026 in Review
Intermede Investment Partners reduced its CME Group (CME) stake by 5.1% in Q1 2026, selling an estimated $4.34M and leaving 270,331 shares worth $79.8M. The position accounts for 3.7% of the portfolio, ranked #10.
Intermede Investment Partners first reported a position in CME in Q4 2015 and has held it in 39 quarters since. The position peaked at $239M in Q1 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Intermede Investment Partners held 270,331 shares of CME Group worth $79.8M as of Q1 2026.
- Intermede Investment Partners sold 14,628 CME Group shares in Q1 2026, an estimated $4.34M.
- CME Group made up 3.7% of Intermede Investment Partners's portfolio in Q1 2026, its #10 holding.
- Intermede Investment Partners first reported a position in CME Group in Q4 2015 and has held it in 39 quarters since.
- Intermede Investment Partners's CME Group position peaked at $239M in Q1 2022.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Intermede Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.